⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLMD News
Relmada Therapeutics, Inc. Common Stock
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
globenewswire.com
RLMD
Relmada Therapeutics to Report Fourth Quarter 2025 Financial Results on Thursday, March 19, 2026
globenewswire.com
RLMD
BioGene Therapeutics Inc. Appoints Raj S. Pruthi, MD, MHA, FACS, as Director Ready to Announce with Confidence?
newsfilecorp.com
RLMD
JNJ
Relmada Therapeutics to Present at the Leerink Partners Global Healthcare Conference
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
globenewswire.com
RLMD
Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing
globenewswire.com
RLMD
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
globenewswire.com
RLMD
Relmada Therapeutics Reports 12-Month Phase 2 Interim Data for NDV-01 in Non-Muscle Invasive Bladder Cancer
globenewswire.com
RLMD
Psychedelic Medicine Advances: Here Are Five Companies Targeting CNS Disorders
prnewswire.com
HELP
AXSM
RLMD
ANRO
CMPS